相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022
Yongbiao Xue et al.
NUCLEIC ACIDS RESEARCH (2022)
STING, a promising target for small molecular immune modulator: A review
Yijun Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah Blythe Doroshow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Phosphorylation and chromatin tethering prevent cGAS activation during mitosis
Tuo Li et al.
SCIENCE (2021)
The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types
Tingting Chen et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
Nuclear Aurora kinase A triggers programmed death-ligand 1-mediated immune suppression by activating MYC transcription in triple-negative breast cancer
Shulan Sun et al.
CANCER COMMUNICATIONS (2021)
Cytosolic DNA sensing by cGAS: regulation, function, and human diseases
Le Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Peter Nash et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Immune-Checkpoint Blockade Therapy in Lymphoma
Ayumi Kuzume et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
cGAS-STING, an important pathway in cancer immunotherapy
Minlin Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Sustained Release of TPCA-1 from Silk Fibroin Hydrogels Preserves Keratocyte Phenotype and Promotes Corneal Regeneration by Inhibiting Interleukin-1β Signaling
Wei Zhang et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro
Zixiong Zhou et al.
TOXICOLOGY (2020)
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Structural basis of STING binding with and phosphorylation by TBK1
Conggang Zhang et al.
NATURE (2019)
A rapid computational approach identifies SPICE1 as an Aurora kinase substrate
Jovana Deretic et al.
MOLECULAR BIOLOGY OF THE CELL (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Alisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors
Susanne Liewer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
Haidong Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression
Heng Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage
Gillian Dunphy et al.
MOLECULAR CELL (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment
Qiaohong Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice
Janet Lau et al.
NATURE COMMUNICATIONS (2017)
Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and CanBe Targeted to Enhance Anti-tumor Response
Vijay K. Gonugunta et al.
CELL REPORTS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor
Cameron T. Durlacher et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
What does PD-L1 positive or negative mean?
Antoni Ribas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
Feimeng Zheng et al.
NATURE COMMUNICATIONS (2016)
PD-1/PD-L1 inhibitors
Joel Sunshine et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
Michael G. Kemp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Aurora kinase A in gastrointestinal cancers: time to target
Ahmed Katsha et al.
MOLECULAR CANCER (2015)
Aurora Kinase inhibitors: Current Status and Outlook
Vassilios Bavetsias et al.
FRONTIERS IN ONCOLOGY (2015)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells
Shuiqing Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Oncogenic Role of Nuclear Accumulated Aurora-A
Masaaki Tatsuka et al.
MOLECULAR CARCINOGENESIS (2009)
Aurora-A: the maker and breaker of spindle poles
Alexis R. Barr et al.
JOURNAL OF CELL SCIENCE (2007)
Phosphate-binding tag, a new tool to visualize phosphorylated proteins
E Kinoshita et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
H Katayama et al.
NATURE GENETICS (2004)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
分享论文
